nodes	percent_of_prediction	percent_of_DWPC	metapath
Danazol—AR—duct of salivary gland—salivary gland cancer	0.201	0.452	CbGeAlD
Danazol—CCL2—neck—salivary gland cancer	0.0272	0.0614	CbGeAlD
Danazol—CCL2—parotid gland—salivary gland cancer	0.0222	0.05	CbGeAlD
Danazol—CCL2—connective tissue—salivary gland cancer	0.0195	0.044	CbGeAlD
Danazol—CCL2—epithelium—salivary gland cancer	0.0185	0.0418	CbGeAlD
Danazol—SHBG—neck—salivary gland cancer	0.0159	0.0358	CbGeAlD
Danazol—CCL2—lymphoid tissue—salivary gland cancer	0.0143	0.0322	CbGeAlD
Danazol—SHBG—connective tissue—salivary gland cancer	0.0114	0.0257	CbGeAlD
Danazol—ESR1—neck—salivary gland cancer	0.0112	0.0252	CbGeAlD
Danazol—PGR—connective tissue—salivary gland cancer	0.0103	0.0231	CbGeAlD
Danazol—PGR—epithelium—salivary gland cancer	0.00974	0.0219	CbGeAlD
Danazol—CYP19A1—connective tissue—salivary gland cancer	0.00923	0.0208	CbGeAlD
Danazol—AR—connective tissue—salivary gland cancer	0.00817	0.0184	CbGeAlD
Danazol—CCL2—lymph node—salivary gland cancer	0.00805	0.0181	CbGeAlD
Danazol—ESR1—connective tissue—salivary gland cancer	0.00802	0.0181	CbGeAlD
Danazol—AR—epithelium—salivary gland cancer	0.00776	0.0175	CbGeAlD
Danazol—ESR1—epithelium—salivary gland cancer	0.00762	0.0172	CbGeAlD
Danazol—PGR—lymphoid tissue—salivary gland cancer	0.0075	0.0169	CbGeAlD
Danazol—AR—lymphoid tissue—salivary gland cancer	0.00598	0.0135	CbGeAlD
Danazol—ESR1—lymphoid tissue—salivary gland cancer	0.00587	0.0132	CbGeAlD
Danazol—PGR—lymph node—salivary gland cancer	0.00423	0.00954	CbGeAlD
Danazol—CYP19A1—lymph node—salivary gland cancer	0.00381	0.00858	CbGeAlD
Danazol—AR—lymph node—salivary gland cancer	0.00337	0.0076	CbGeAlD
Danazol—ESR1—lymph node—salivary gland cancer	0.00331	0.00746	CbGeAlD
Danazol—AR—Generic Transcription Pathway—MAML3—salivary gland cancer	0.00137	0.00246	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—BRCA1—salivary gland cancer	0.00136	0.00244	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—MC3R—salivary gland cancer	0.00134	0.00242	CbGpPWpGaD
Danazol—ESR1—Regulation of Telomerase—ATM—salivary gland cancer	0.00133	0.0024	CbGpPWpGaD
Danazol—AR—Nongenotropic Androgen signaling—HRAS—salivary gland cancer	0.00132	0.00237	CbGpPWpGaD
Danazol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—salivary gland cancer	0.00131	0.00236	CbGpPWpGaD
Danazol—AR—Regulation of nuclear SMAD2/3 signaling—CREBBP—salivary gland cancer	0.00131	0.00235	CbGpPWpGaD
Danazol—ESR1—FOXM1 transcription factor network—CCND1—salivary gland cancer	0.00126	0.00227	CbGpPWpGaD
Danazol—CCL2—TNF alpha Signaling Pathway—HRAS—salivary gland cancer	0.00125	0.00225	CbGpPWpGaD
Danazol—AR—Gene Expression—UHRF1—salivary gland cancer	0.00125	0.00225	CbGpPWpGaD
Danazol—AR—Regulation of Androgen receptor activity—EP300—salivary gland cancer	0.00125	0.00225	CbGpPWpGaD
Danazol—PGR—Gene Expression—ARID4B—salivary gland cancer	0.00125	0.00224	CbGpPWpGaD
Danazol—PGR—Gene Expression—NFIB—salivary gland cancer	0.00125	0.00224	CbGpPWpGaD
Danazol—AR—Coregulation of Androgen receptor activity—CCND1—salivary gland cancer	0.00122	0.00218	CbGpPWpGaD
Danazol—AR—Androgen receptor signaling pathway—CREBBP—salivary gland cancer	0.00121	0.00218	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—FGFR4—salivary gland cancer	0.00121	0.00218	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—BRCA1—salivary gland cancer	0.00117	0.0021	CbGpPWpGaD
Danazol—ESR1—FOXM1 transcription factor network—EP300—salivary gland cancer	0.00116	0.00209	CbGpPWpGaD
Danazol—ESR1—Gene Expression—ZIM2—salivary gland cancer	0.00113	0.00204	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—BRCA1—salivary gland cancer	0.00113	0.00202	CbGpPWpGaD
Danazol—ESR1—FOXA1 transcription factor network—EP300—salivary gland cancer	0.00112	0.00201	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—WNT5B—salivary gland cancer	0.0011	0.00198	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—TOP2A—salivary gland cancer	0.00109	0.00195	CbGpPWpGaD
Danazol—ESR1—Aryl Hydrocarbon Receptor—EP300—salivary gland cancer	0.00108	0.00194	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—TP53—salivary gland cancer	0.00107	0.00193	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IL17RD—salivary gland cancer	0.00106	0.00191	CbGpPWpGaD
Danazol—CCL2—Metabolism of proteins—FBXW7—salivary gland cancer	0.00106	0.0019	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—MAML3—salivary gland cancer	0.00105	0.00189	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—BRCA1—salivary gland cancer	0.00105	0.00188	CbGpPWpGaD
Danazol—ESR1—Regulation of nuclear SMAD2/3 signaling—CREBBP—salivary gland cancer	0.00101	0.00181	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—WNT5B—salivary gland cancer	0.00101	0.00181	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—FOXO3—salivary gland cancer	0.001	0.00181	CbGpPWpGaD
Danazol—PGR—Generic Transcription Pathway—MAML2—salivary gland cancer	0.001	0.00181	CbGpPWpGaD
Danazol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—salivary gland cancer	0.000978	0.00176	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MAML3—salivary gland cancer	0.000974	0.00175	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IL17RD—salivary gland cancer	0.000974	0.00175	CbGpPWpGaD
Danazol—ESR1—Gene Expression—UHRF1—salivary gland cancer	0.000965	0.00173	CbGpPWpGaD
Danazol—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—salivary gland cancer	0.000962	0.00173	CbGpPWpGaD
Danazol—ESR1—ATF-2 transcription factor network—CCND1—salivary gland cancer	0.000962	0.00173	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—ERBB2IP—salivary gland cancer	0.000953	0.00171	CbGpPWpGaD
Danazol—AR—Gene Expression—ARID4B—salivary gland cancer	0.000949	0.00171	CbGpPWpGaD
Danazol—AR—Gene Expression—NFIB—salivary gland cancer	0.000949	0.00171	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—ATM—salivary gland cancer	0.000915	0.00165	CbGpPWpGaD
Danazol—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—salivary gland cancer	0.000901	0.00162	CbGpPWpGaD
Danazol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—salivary gland cancer	0.000901	0.00162	CbGpPWpGaD
Danazol—AR—Androgen receptor signaling pathway—CCND1—salivary gland cancer	0.000898	0.00162	CbGpPWpGaD
Danazol—AR—Regulation of nuclear SMAD2/3 signaling—EP300—salivary gland cancer	0.000892	0.0016	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MAML3—salivary gland cancer	0.000891	0.0016	CbGpPWpGaD
Danazol—ESR1—ATF-2 transcription factor network—EP300—salivary gland cancer	0.000885	0.00159	CbGpPWpGaD
Danazol—ESR1—Plasma membrane estrogen receptor signaling—PIK3CA—salivary gland cancer	0.000876	0.00157	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MC3R—salivary gland cancer	0.000868	0.00156	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—BRCA1—salivary gland cancer	0.000867	0.00156	CbGpPWpGaD
Danazol—AR—Androgen receptor signaling pathway—PTEN—salivary gland cancer	0.000867	0.00156	CbGpPWpGaD
Danazol—PGR—Gene Expression—MAML3—salivary gland cancer	0.000864	0.00155	CbGpPWpGaD
Danazol—ESR1—Regulation of Telomerase—CCND1—salivary gland cancer	0.000858	0.00154	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—CCND1—salivary gland cancer	0.000839	0.00151	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—ST3GAL4—salivary gland cancer	0.000835	0.0015	CbGpPWpGaD
Danazol—ESR1—Validated nuclear estrogen receptor alpha network—EP300—salivary gland cancer	0.000829	0.00149	CbGpPWpGaD
Danazol—AR—Androgen receptor signaling pathway—EP300—salivary gland cancer	0.000827	0.00149	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—MAP2K2—salivary gland cancer	0.000821	0.00148	CbGpPWpGaD
Danazol—ESR1—LKB1 signaling events—TP53—salivary gland cancer	0.000816	0.00147	CbGpPWpGaD
Danazol—ESR1—Plasma membrane estrogen receptor signaling—HRAS—salivary gland cancer	0.000811	0.00146	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—PTEN—salivary gland cancer	0.000809	0.00146	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MC3R—salivary gland cancer	0.000794	0.00143	CbGpPWpGaD
Danazol—ESR1—Leptin signaling pathway—CCND1—salivary gland cancer	0.000794	0.00143	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—CDH1—salivary gland cancer	0.00079	0.00142	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—ATM—salivary gland cancer	0.000788	0.00142	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—CREBBP—salivary gland cancer	0.000775	0.00139	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—EP300—salivary gland cancer	0.000772	0.00139	CbGpPWpGaD
Danazol—AR—Generic Transcription Pathway—MAML2—salivary gland cancer	0.000765	0.00138	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—ST3GAL4—salivary gland cancer	0.000764	0.00137	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—DTX4—salivary gland cancer	0.000759	0.00136	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—ATM—salivary gland cancer	0.000758	0.00136	CbGpPWpGaD
Danazol—PGR—Signaling by ERBB4—PTEN—salivary gland cancer	0.000742	0.00133	CbGpPWpGaD
Danazol—ESR1—Aryl Hydrocarbon Receptor—HRAS—salivary gland cancer	0.000739	0.00133	CbGpPWpGaD
Danazol—ESR1—Gene Expression—ARID4B—salivary gland cancer	0.000731	0.00131	CbGpPWpGaD
Danazol—ESR1—Gene Expression—NFIB—salivary gland cancer	0.000731	0.00131	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—ATM—salivary gland cancer	0.000705	0.00127	CbGpPWpGaD
Danazol—GNRHR—G alpha (q) signalling events—PIK3CA—salivary gland cancer	0.000703	0.00126	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—DTX4—salivary gland cancer	0.000694	0.00125	CbGpPWpGaD
Danazol—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—salivary gland cancer	0.000687	0.00123	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—CDH1—salivary gland cancer	0.000679	0.00122	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—CREBBP—salivary gland cancer	0.000659	0.00118	CbGpPWpGaD
Danazol—AR—Gene Expression—MAML3—salivary gland cancer	0.000658	0.00118	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—WNT5B—salivary gland cancer	0.000636	0.00114	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ISYNA1—salivary gland cancer	0.000635	0.00114	CbGpPWpGaD
Danazol—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—salivary gland cancer	0.000629	0.00113	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—FGF16—salivary gland cancer	0.000627	0.00113	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IL17RD—salivary gland cancer	0.000614	0.0011	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—CDH1—salivary gland cancer	0.000608	0.00109	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—MAML2—salivary gland cancer	0.000589	0.00106	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—CCND1—salivary gland cancer	0.000589	0.00106	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—ATM—salivary gland cancer	0.000584	0.00105	CbGpPWpGaD
Danazol—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—salivary gland cancer	0.000582	0.00105	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—FGF16—salivary gland cancer	0.000574	0.00103	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—PTEN—salivary gland cancer	0.000568	0.00102	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MAML3—salivary gland cancer	0.000562	0.00101	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ERBB2IP—salivary gland cancer	0.000559	0.00101	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—TP53—salivary gland cancer	0.000552	0.000993	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MAML2—salivary gland cancer	0.000545	0.00098	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—EP300—salivary gland cancer	0.000542	0.000974	CbGpPWpGaD
Danazol—PGR—Gene Expression—NUP62—salivary gland cancer	0.000534	0.000959	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—MAP2K2—salivary gland cancer	0.000532	0.000956	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—EP300—salivary gland cancer	0.000528	0.000949	CbGpPWpGaD
Danazol—PGR—Signaling by ERBB4—PIK3CA—salivary gland cancer	0.000523	0.000941	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—MARCKS—salivary gland cancer	0.000518	0.000931	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—CREBBP—salivary gland cancer	0.000508	0.000913	CbGpPWpGaD
Danazol—ESR1—Gene Expression—MAML3—salivary gland cancer	0.000507	0.000911	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—CCND1—salivary gland cancer	0.000506	0.00091	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MC3R—salivary gland cancer	0.000501	0.0009	CbGpPWpGaD
Danazol—ESR1—Leptin signaling pathway—HRAS—salivary gland cancer	0.0005	0.000899	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MAML2—salivary gland cancer	0.000498	0.000896	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—PTEN—salivary gland cancer	0.000489	0.000879	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	0.000488	0.000877	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—MAP2K2—salivary gland cancer	0.000486	0.000874	CbGpPWpGaD
Danazol—PGR—Signaling by ERBB4—HRAS—salivary gland cancer	0.000484	0.00087	CbGpPWpGaD
Danazol—PGR—Gene Expression—MAML2—salivary gland cancer	0.000483	0.000869	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—ST3GAL4—salivary gland cancer	0.000482	0.000866	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PYGB—salivary gland cancer	0.000481	0.000865	CbGpPWpGaD
Danazol—PGR—Generic Transcription Pathway—NOTCH1—salivary gland cancer	0.000474	0.000852	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	0.000471	0.000846	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—EP300—salivary gland cancer	0.000466	0.000838	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—JAG1—salivary gland cancer	0.000465	0.000837	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—FGFR4—salivary gland cancer	0.000463	0.000833	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—FBXW7—salivary gland cancer	0.000456	0.00082	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—CCND1—salivary gland cancer	0.000453	0.000815	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	0.000449	0.000807	CbGpPWpGaD
Danazol—PGR—Gene Expression—SMC1A—salivary gland cancer	0.000447	0.000803	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—PTEN—salivary gland cancer	0.000438	0.000787	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—DTX4—salivary gland cancer	0.000438	0.000787	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—PTEN—salivary gland cancer	0.000435	0.000783	CbGpPWpGaD
Danazol—PGR—Generic Transcription Pathway—CREBBP—salivary gland cancer	0.00043	0.000773	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—JAG1—salivary gland cancer	0.000426	0.000765	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—FGFR4—salivary gland cancer	0.000424	0.000762	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—EP300—salivary gland cancer	0.000417	0.00075	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—FBXW7—salivary gland cancer	0.000417	0.00075	CbGpPWpGaD
Danazol—AR—Gene Expression—NUP62—salivary gland cancer	0.000407	0.000731	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PHGDH—salivary gland cancer	0.000392	0.000705	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—TP53—salivary gland cancer	0.000388	0.000697	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—FOXO3—salivary gland cancer	0.000385	0.000691	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ST3GAL4—salivary gland cancer	0.000378	0.000679	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	0.000376	0.000675	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—WNT5B—salivary gland cancer	0.000373	0.000671	CbGpPWpGaD
Danazol—AR—Gene Expression—MAML2—salivary gland cancer	0.000368	0.000662	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	0.000363	0.000652	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—FGF16—salivary gland cancer	0.000362	0.000651	CbGpPWpGaD
Danazol—AR—Generic Transcription Pathway—NOTCH1—salivary gland cancer	0.000361	0.000649	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IL17RD—salivary gland cancer	0.00036	0.000648	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—FOXO3—salivary gland cancer	0.000352	0.000632	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	0.000346	0.000622	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—AQP1—salivary gland cancer	0.000343	0.000617	CbGpPWpGaD
Danazol—AR—Gene Expression—SMC1A—salivary gland cancer	0.00034	0.000612	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—TP53—salivary gland cancer	0.000334	0.0006	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.000332	0.000597	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MAML3—salivary gland cancer	0.00033	0.000593	CbGpPWpGaD
Danazol—AR—Generic Transcription Pathway—CREBBP—salivary gland cancer	0.000327	0.000589	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.000321	0.000578	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MAML2—salivary gland cancer	0.000314	0.000565	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MAP2K2—salivary gland cancer	0.000314	0.000564	CbGpPWpGaD
Danazol—ESR1—Gene Expression—NUP62—salivary gland cancer	0.000313	0.000563	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—PIK3CA—salivary gland cancer	0.000307	0.000552	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—TP53—salivary gland cancer	0.000299	0.000537	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MC3R—salivary gland cancer	0.000294	0.000528	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MAP2K2—salivary gland cancer	0.000287	0.000516	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—HRAS—salivary gland cancer	0.000284	0.000511	CbGpPWpGaD
Danazol—ESR1—Gene Expression—MAML2—salivary gland cancer	0.000284	0.00051	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ST3GAL4—salivary gland cancer	0.000283	0.000508	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—NOTCH1—salivary gland cancer	0.000278	0.0005	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—NUP62—salivary gland cancer	0.000272	0.000489	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—VCAN—salivary gland cancer	0.00027	0.000485	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—JAG1—salivary gland cancer	0.000268	0.000482	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—FGFR4—salivary gland cancer	0.000267	0.00048	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—FBXW7—salivary gland cancer	0.000263	0.000473	CbGpPWpGaD
Danazol—ESR1—Gene Expression—SMC1A—salivary gland cancer	0.000262	0.000471	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—NOTCH1—salivary gland cancer	0.000257	0.000462	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—DTX4—salivary gland cancer	0.000257	0.000462	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.000256	0.00046	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—CREBBP—salivary gland cancer	0.000252	0.000453	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.000247	0.000445	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000237	0.000426	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—NOTCH1—salivary gland cancer	0.000235	0.000423	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CREBBP—salivary gland cancer	0.000233	0.000419	CbGpPWpGaD
Danazol—PGR—Gene Expression—NOTCH1—salivary gland cancer	0.000228	0.00041	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—FOXO3—salivary gland cancer	0.000222	0.000399	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CREBBP—salivary gland cancer	0.000213	0.000384	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—FGF16—salivary gland cancer	0.000212	0.000382	CbGpPWpGaD
Danazol—PGR—Gene Expression—CREBBP—salivary gland cancer	0.000207	0.000372	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.0002	0.00036	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000199	0.000358	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ISYNA1—salivary gland cancer	0.000185	0.000333	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MAML2—salivary gland cancer	0.000184	0.000332	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—HRAS—salivary gland cancer	0.000184	0.000331	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000182	0.000327	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MAP2K2—salivary gland cancer	0.000181	0.000326	CbGpPWpGaD
Danazol—AR—Gene Expression—NOTCH1—salivary gland cancer	0.000174	0.000313	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CCND1—salivary gland cancer	0.000173	0.00031	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000169	0.000304	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—HRAS—salivary gland cancer	0.000168	0.000303	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PTEN—salivary gland cancer	0.000167	0.000299	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000161	0.00029	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—EP300—salivary gland cancer	0.000159	0.000286	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CCND1—salivary gland cancer	0.000158	0.000284	CbGpPWpGaD
Danazol—AR—Gene Expression—CREBBP—salivary gland cancer	0.000158	0.000283	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—JAG1—salivary gland cancer	0.000158	0.000283	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—FGFR4—salivary gland cancer	0.000157	0.000282	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—FBXW7—salivary gland cancer	0.000154	0.000277	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PTEN—salivary gland cancer	0.000152	0.000274	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—MARCKS—salivary gland cancer	0.000151	0.000272	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NOTCH1—salivary gland cancer	0.000148	0.000267	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—EP300—salivary gland cancer	0.000145	0.000261	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PYGB—salivary gland cancer	0.00014	0.000253	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CREBBP—salivary gland cancer	0.000135	0.000242	CbGpPWpGaD
Danazol—ESR1—Gene Expression—NOTCH1—salivary gland cancer	0.000134	0.000241	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—FOXO3—salivary gland cancer	0.00013	0.000234	CbGpPWpGaD
Danazol—ESR1—Gene Expression—CREBBP—salivary gland cancer	0.000121	0.000218	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.000119	0.000215	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PIK3CA—salivary gland cancer	0.000118	0.000211	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PHGDH—salivary gland cancer	0.000115	0.000206	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TP53—salivary gland cancer	0.000114	0.000204	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ST3GAL4—salivary gland cancer	0.00011	0.000198	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—HRAS—salivary gland cancer	0.000109	0.000195	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PIK3CA—salivary gland cancer	0.000107	0.000193	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MAP2K2—salivary gland cancer	0.000106	0.000191	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CREBBP—salivary gland cancer	0.000105	0.00019	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TP53—salivary gland cancer	0.000104	0.000187	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—AQP1—salivary gland cancer	0.0001	0.00018	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CCND1—salivary gland cancer	9.95e-05	0.000179	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—HRAS—salivary gland cancer	9.94e-05	0.000179	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PTEN—salivary gland cancer	9.61e-05	0.000173	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—EP300—salivary gland cancer	9.16e-05	0.000165	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NOTCH1—salivary gland cancer	8.71e-05	0.000157	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NUP62—salivary gland cancer	7.94e-05	0.000143	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CREBBP—salivary gland cancer	7.9e-05	0.000142	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—VCAN—salivary gland cancer	7.88e-05	0.000142	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PTEN—salivary gland cancer	7.53e-05	0.000135	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—EP300—salivary gland cancer	7.18e-05	0.000129	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PIK3CA—salivary gland cancer	6.78e-05	0.000122	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TP53—salivary gland cancer	6.56e-05	0.000118	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—HRAS—salivary gland cancer	6.27e-05	0.000113	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCND1—salivary gland cancer	5.84e-05	0.000105	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PTEN—salivary gland cancer	5.64e-05	0.000101	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—EP300—salivary gland cancer	5.38e-05	9.67e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PIK3CA—salivary gland cancer	5.31e-05	9.55e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PIK3CA—salivary gland cancer	3.98e-05	7.15e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TP53—salivary gland cancer	3.85e-05	6.92e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HRAS—salivary gland cancer	3.68e-05	6.62e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CREBBP—salivary gland cancer	3.08e-05	5.53e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PTEN—salivary gland cancer	2.2e-05	3.95e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—EP300—salivary gland cancer	2.1e-05	3.77e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PIK3CA—salivary gland cancer	1.55e-05	2.79e-05	CbGpPWpGaD
